Total Payments
$504.36
2024 Payments
$114.12
Companies
10
Transactions
24
Medicare Patients
97
Medicare Billing
$9,472
Payment Breakdown by Category
Food & Beverage$457.45 (90.7%)
Education$46.91 (9.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $457.45 | 23 | 90.7% |
| Education | $46.91 | 1 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $136.51 | 7 | $0 (2023) |
| ABBVIE INC. | $107.72 | 5 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $48.80 | 3 | $0 (2022) |
| ITI, Inc. | $46.91 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $44.97 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $42.23 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $29.02 | 1 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $18.67 | 1 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $16.22 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $13.31 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $114.12 | 5 | E.R. Squibb & Sons, L.L.C. ($44.97) |
| 2023 | $65.98 | 3 | Alkermes, Inc. ($26.55) |
| 2022 | $227.75 | 12 | Alkermes, Inc. ($98.11) |
| 2021 | $96.51 | 4 | ITI, Inc. ($46.91) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.24 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $21.73 | General |
| 08/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Neurology | ||||||
| 01/27/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: CNS | ||||||
| 09/27/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: CNS | ||||||
| 08/22/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: CNS | ||||||
| 07/19/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: CNS | ||||||
| 07/06/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: CNS | ||||||
| 05/26/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Central Nervous System | ||||||
| 05/17/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: CNS | ||||||
| 05/11/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Neuropsychiatry | ||||||
| 05/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Neuroscience | ||||||
| 02/28/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: CNS | ||||||
| 02/10/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: CNS | ||||||
| 01/24/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: CNS | ||||||
| 09/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: CNS | ||||||
| 04/27/2021 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $46.91 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 56 | $8,457 | $2,084 |
| 2022 | 1 | 18 | 59 | $8,339 | $2,202 |
| 2021 | 2 | 31 | 66 | $8,913 | $2,631 |
| 2020 | 2 | 34 | 87 | $11,665 | $2,555 |
Total Patients
97
Total Services
268
Medicare Billing
$9,472
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 56 | $8,457 | $2,084 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 18 | 59 | $8,339 | $2,202 | 26.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 19 | 38 | $5,132 | $1,531 | 29.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 12 | 28 | $3,781 | $1,100 | 29.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 19 | 48 | $6,432 | $1,316 | 20.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 15 | 39 | $5,233 | $1,240 | 23.7% |
About Stephanie Bizzari
Stephanie Bizzari is a Clinical healthcare provider based in Auburn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2011. The National Provider Identifier (NPI) number assigned to this provider is 1013212984.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Bizzari has received a total of $504.36 in payments from pharmaceutical and medical device companies, with $114.12 received in 2024. These payments were reported across 24 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($457.45).
As a Medicare-enrolled provider, Bizzari has provided services to 97 Medicare beneficiaries, totaling 268 services with total Medicare billing of $9,472. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical
- Other Specialties Registered Nurse, Psychiatric/Mental Health
- Location Auburn, NY
- Active Since 01/24/2011
- Last Updated 07/21/2022
- Taxonomy Code 1041C0700X
- Entity Type Individual
- NPI Number 1013212984
Products in Payments
- ARISTADA (Drug) $136.51
- VRAYLAR (Drug) $107.72
- LATUDA (Drug) $48.80
- CAPLYTA (Drug) $46.91
- ABILIFY MAINTENA (Drug) $29.02
- AUSTEDO (Drug) $28.87
- COBENFY (Drug) $23.24
- INGREZZA (Drug) $18.67
- Qelbree (Drug) $16.22
- UZEDY (Drug) $13.36
- SPRAVATO (Drug) $13.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.